Cargando…

Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients

Patients with coronavirus disease 19 (COVID-19) admitted to the intensive care unit (ICU) often develop respiratory fungal infections. The most frequent diseases are the COVID-19 associated pulmonary aspergillosis (CAPA), COVID-19 associated pulmonary mucormycosis (CAPM) and the Pneumocystis jirovec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raffaelli, Francesca, Tanzarella, Eloisa Sofia, De Pascale, Gennaro, Tumbarello, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025868/ https://www.ncbi.nlm.nih.gov/pubmed/35448646 http://dx.doi.org/10.3390/jof8040415

Ejemplares similares

Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial
por: Menga, Luca S., et al.
Publicado: (2021)

Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2023)

Vitamin D Status and Potential Therapeutic Options in Critically Ill Patients: A Narrative Review of the Clinical Evidence
por: Cutuli, Salvatore L., et al.
Publicado: (2022)

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014)

317. Invasive Fungal Infections in Critically-ill Patients with COVID-19 in Mexico City
por: Bojorges-Aguilar, Eduardo S, et al.
Publicado: (2021)

Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis
por: De Pascale, Gennaro, et al.
Publicado: (2021)

Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
por: Rovina, Nikoletta, et al.
Publicado: (2022)

Invasive fungal infections in critically ill COVID-19 patients in a large tertiary university hospital in Israel
por: Ayalon, Oshrat, et al.
Publicado: (2022)

Invasiveness of Ventilation Therapy Is Associated to Prevalence of Secondary Bacterial and Fungal Infections in Critically Ill COVID-19 Patients
por: de Hesselle, Marie Louise, et al.
Publicado: (2022)

New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
por: Losito, Angela Raffaella, et al.
Publicado: (2022)

Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation
por: De Pascale, Gennaro, et al.
Publicado: (2022)

An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE
por: Tanzarella, Eloisa Sofia, et al.
Publicado: (2023)

Fungal colonization and infection in critically ill patients
por: Lorente, L, et al.
Publicado: (2005)

Invasive fungal infections among critically ill children: Epidemiology, risk factors and outcomes
por: Hlophe, S T, et al.
Publicado: (2018)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary
por: Szabo, Balint Gergely, et al.
Publicado: (2021)

(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies
por: Azoulay, Elie, et al.
Publicado: (2016)

Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies
por: Grieco, Domenico Luca, et al.
Publicado: (2020)

1170. Invasive Fungal Infections and Colonization in Critically Ill Patients: Impact of Diagnosis and Management on Outcomes
por: Siudela, Anthony, et al.
Publicado: (2020)

No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment
por: Bienvenu, Anne-Lise, et al.
Publicado: (2020)

Risk factors for early invasive fungal disease in critically ill patients
por: Singh, Gurmeet, et al.
Publicado: (2016)

Risk factors for early invasive fungal disease in critically ill patients
por: Sai Saran, P. V., et al.
Publicado: (2016)

Hospital-Acquired Infections in Critically Ill Patients With COVID-19
por: Grasselli, Giacomo, et al.
Publicado: (2021)

Antifungal stewardship in critically ill patients
por: De Pascale, Gennaro, et al.
Publicado: (2023)

Hemodynamic response to positive end-expiratory pressure and prone position in COVID-19 ARDS
por: Dell’Anna, Antonio Maria, et al.
Publicado: (2022)

Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study
por: Rando, Emanuele, et al.
Publicado: (2023)

Combination antifungal treatment in critically ill patients failing first-line therapy for invasive fungal infections
por: Pagani, L, et al.
Publicado: (2006)

Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants
por: Ezeokoli, Obinna T., et al.
Publicado: (2021)

PREDICTORS AND OUTCOMES OF BACTERIAL AND FUNGAL SUPERINFECTIONS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: YAQOOB, HAMID, et al.
Publicado: (2021)

Invasive Fungal Infections Associated with COVID-19
por: Hlaing, Kyaw M., et al.
Publicado: (2023)

Use of an innovative cuff pressure control and subglottic secretions drainage system in COVID-19 ARDS patients undergoing pronation
por: Tanzarella, Eloisa Sofia, et al.
Publicado: (2022)

Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy
por: Stella, Claudia, et al.
Publicado: (2023)

COVID-19 influences lung microbiota dynamics and favors the emergence of rare infectious diseases: A case report of Hafnia Alvei pneumonia.
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2021)

Immune Modulation in Critically Ill Septic Patients
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2021)

Vitamin D status in critically ill patients: the evidence is now bioavailable!
por: De Pascale, Gennaro, et al.
Publicado: (2014)

Overview of COVID-19-Associated Invasive Fungal Infection
por: Shishido, Akira A., et al.
Publicado: (2022)

XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?
por: Del Giacomo, Paola, et al.
Publicado: (2022)

Emerging Invasive Fungal Infections in Critically Ill Patients: Incidence, Outcomes and Prognosis Factors, a Case-Control Study
por: Larcher, Romaric, et al.
Publicado: (2021)

The Role of Antifungals in Pediatric Critical Care Invasive Fungal Infections
por: Kaushik, Ashlesha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ftrnmfdgdk978j629pp7ufidju